These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 16181240

  • 1. No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.
    Liu RT, Chen YJ, Chou FF, Li CL, Wu WL, Tsai PC, Huang CC, Cheng JT.
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):461-6. PubMed ID: 16181240
    [Abstract] [Full Text] [Related]

  • 2. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
    Costa AM, Herrero A, Fresno MF, Heymann J, Alvarez JA, Cameselle-Teijeiro J, García-Rostán G.
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
    [Abstract] [Full Text] [Related]

  • 3. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).
    Carta C, Moretti S, Passeri L, Barbi F, Avenia N, Cavaliere A, Monacelli M, Macchiarulo A, Santeusanio F, Tartaglia M, Puxeddu E.
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937
    [Abstract] [Full Text] [Related]

  • 4. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA.
    Cancer Res; 2003 Aug 01; 63(15):4561-7. PubMed ID: 12907632
    [Abstract] [Full Text] [Related]

  • 5. [Molecular analysis of structural abnormalities in papillary thyroid carcinoma gene].
    Vasil'ev EV, Rumiantsev PO, Saenko VA, Il'in AA, Poliakova EIu, Nemtsova MV, Zaletaev DV.
    Mol Biol (Mosk); 2004 Aug 01; 38(4):642-53. PubMed ID: 15456136
    [Abstract] [Full Text] [Related]

  • 6. BRAF mutations in an Italian cohort of thyroid cancers.
    Fugazzola L, Mannavola D, Cirello V, Vannucchi G, Muzza M, Vicentini L, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2004 Aug 01; 61(2):239-43. PubMed ID: 15272920
    [Abstract] [Full Text] [Related]

  • 7. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X.
    Cancer; 2005 Jun 01; 103(11):2261-8. PubMed ID: 15880523
    [Abstract] [Full Text] [Related]

  • 8. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
    Romei C, Ciampi R, Faviana P, Agate L, Molinaro E, Bottici V, Basolo F, Miccoli P, Pacini F, Pinchera A, Elisei R.
    Endocr Relat Cancer; 2008 Jun 01; 15(2):511-20. PubMed ID: 18509003
    [Abstract] [Full Text] [Related]

  • 9. [BRAF gene mutation in thyroid cancer].
    Kopczyńska E, Junik R, Tyrakowski T.
    Pol Merkur Lekarski; 2006 Feb 01; 20(116):210-3. PubMed ID: 16708643
    [Abstract] [Full Text] [Related]

  • 10. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.
    Fugazzola L, Puxeddu E, Avenia N, Romei C, Cirello V, Cavaliere A, Faviana P, Mannavola D, Moretti S, Rossi S, Sculli M, Bottici V, Beck-Peccoz P, Pacini F, Pinchera A, Santeusanio F, Elisei R.
    Endocr Relat Cancer; 2006 Jun 01; 13(2):455-64. PubMed ID: 16728573
    [Abstract] [Full Text] [Related]

  • 11. [An investigation of BRAF mutation in papillary thyroid carcinoma and its clinical value].
    Gong RX, Zhou Y, Luo SH, Zhang L, Zhou B.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun 01; 26(3):310-3. PubMed ID: 19504446
    [Abstract] [Full Text] [Related]

  • 12. BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas.
    Lee JH, Lee ES, Kim YS, Won NH, Chae YS.
    Pathology; 2006 Jun 01; 38(3):201-4. PubMed ID: 16753739
    [Abstract] [Full Text] [Related]

  • 13. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
    Paulson L, Shindo M, Schuff K, Corless C.
    Arch Otolaryngol Head Neck Surg; 2012 Jan 01; 138(1):44-9. PubMed ID: 22249628
    [Abstract] [Full Text] [Related]

  • 14. Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population.
    Brzeziańska E, Karbownik M, Migdalska-Sek M, Pastuszak-Lewandoska D, Włoch J, Lewiński A.
    Mutat Res; 2006 Jul 25; 599(1-2):26-35. PubMed ID: 16483615
    [Abstract] [Full Text] [Related]

  • 15. BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas.
    Puxeddu E, Moretti S, Elisei R, Romei C, Pascucci R, Martinelli M, Marino C, Avenia N, Rossi ED, Fadda G, Cavaliere A, Ribacchi R, Falorni A, Pontecorvi A, Pacini F, Pinchera A, Santeusanio F.
    J Clin Endocrinol Metab; 2004 May 25; 89(5):2414-20. PubMed ID: 15126572
    [Abstract] [Full Text] [Related]

  • 16. BRAF mutations in papillary thyroid carcinoma.
    Wojciechowska K, Lewinski A.
    Endocr Regul; 2006 Dec 25; 40(4):129-38. PubMed ID: 17201587
    [Abstract] [Full Text] [Related]

  • 17. BRAF(V600E) mutation and the biology of papillary thyroid cancer.
    Frasca F, Nucera C, Pellegriti G, Gangemi P, Attard M, Stella M, Loda M, Vella V, Giordano C, Trimarchi F, Mazzon E, Belfiore A, Vigneri R.
    Endocr Relat Cancer; 2008 Mar 25; 15(1):191-205. PubMed ID: 18310287
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of BRAF (V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas.
    Nakayama H, Yoshida A, Nakamura Y, Hayashi H, Miyagi Y, Wada N, Rino Y, Masuda M, Imada T.
    Anticancer Res; 2007 Mar 25; 27(5B):3645-9. PubMed ID: 17972530
    [Abstract] [Full Text] [Related]

  • 19. BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid <or=1 cm and their paired lymph node metastases.
    Rodolico V, Cabibi D, Pizzolanti G, Richiusa P, Gebbia N, Martorana A, Russo A, Amato MC, Galluzzo A, Giordano C.
    Cancer; 2007 Sep 15; 110(6):1218-26. PubMed ID: 17685465
    [Abstract] [Full Text] [Related]

  • 20. BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort.
    Goutas N, Vlachodimitropoulos D, Bouka M, Lazaris AC, Nasioulas G, Gazouli M.
    Anticancer Res; 2008 Sep 15; 28(1A):305-8. PubMed ID: 18383861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.